HPE
57
4
APH
68
3
ICE
64
-3
AAP
24
-3
EW
38
2
SWN
42
-4
GILD
47
-3
MUR
38
-6
CCL
50
-3
FDX
51
-2
WEC
46
-4
NWL
19
-9
HUM
31
-4
WY
37
-5
GM
63
-3
SNA
53
-2
NUE
34
-5
ZTS
47
-7
URBN
67
-3
MMM
28
-5
HPE
57
4
APH
68
3
ICE
64
-3
AAP
24
-3
EW
38
2
SWN
42
-4
GILD
47
-3
MUR
38
-6
CCL
50
-3
FDX
51
-2
WEC
46
-4
NWL
19
-9
HUM
31
-4
WY
37
-5
GM
63
-3
SNA
53
-2
NUE
34
-5
ZTS
47
-7
URBN
67
-3
MMM
28
-5
Financhill
Back

Invesco S&P Emerging Markets Low Vol ETF Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison

Sell
34

EELV
Invesco S&P Emerging Markets Low Vol ETF

Last Price:
23.44
Seasonality Move:
0.42%
Sell
49

CRBP
Corbus Pharmaceuticals Holdings

Last Price:
43.06
Seasonality Move:
-11.02%
Sell
34
Invesco S&P Emerging Markets Low Vol ETF (EELV) is a Sell

Is Invesco S&P Emerging Markets Low Vol ETF a Buy, Sell or Hold?

  • The current Invesco S&P Emerging Markets Low Vol ETF [EELV] share price is $23.58. The Score for EELV is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • EELV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Corbus Pharmaceuticals Holdings (CRBP) is a Sell

Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?

  • The current Corbus Pharmaceuticals Holdings [CRBP] share price is $44.30. The Score for CRBP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CRBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EELV Stock Price Chart

What is Invesco S&P Emerging Markets Low Vol ETF's stock price today?

  • The Invesco S&P Emerging Markets Low Vol ETF share price today is $23.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EELV is experiencing selling pressure, which indicates risk of future bearish movement.

CRBP Stock Price Chart

What is Corbus Pharmaceuticals Holdings's stock price today?

EELV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 42.2 Sell
Chaikin Money Flow: -47546 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.61 - 24.05) Sell
Bollinger Bands (100): (23.54 - 24.12) Sell

CRBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.34 Buy
Relative Strength Index (14 RSI): 49.14 Sell
Chaikin Money Flow: -68505 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.41 - 48.51) Sell
Bollinger Bands (100): (30.43 - 45.69) Buy

EELV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.75 Sell
20-day SMA: 23.74 Sell
50-day SMA: 23.79 Sell
200-day SMA: 23.45 Buy
8-day EMA: 23.74 Sell
20-day EMA: 23.78 Sell
50-day EMA: 23.82 Sell
200-day EMA: 23.64 Sell

CRBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.47 Sell
20-day SMA: 45.57 Sell
50-day SMA: 42.55 Buy
200-day SMA: 22.33 Buy
8-day EMA: 44.69 Sell
20-day EMA: 45.06 Sell
50-day EMA: 42.58 Buy
200-day EMA: 27.79 Buy

Invesco S&P Emerging Markets Low Vol ETF Earnings Growth & EELV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.28 per share, an increase this year of $5.53 per share, and an increase next year of $0.35 per share.

Invesco S&P Emerging Markets Low Vol ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corbus Pharmaceuticals Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):